CompletedNot Applicable

Short- and Medium-term Outcomes of the 3- Versus 4-week PV RehaJET® Rehabilitation Programme

Austria499 participantsStarted 2026-07-07

Plain-language summary

The objective of this observational study is to evaluate and compare the outcomes of two different durations of a recently established work-specific rehabilitation programme in Austria. The programme focuses on exercises tailored to patients' individual vocational needs. Two patient groups are observed: one group completes a three-week work-specific rehabilitation programme, while the other group completes a four-week work-specific rehabilitation programme, allowing a direct comparison of their outcomes.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The study participants are patients undergoing the REHAJET programme * Presence of a disease in the area of the musculoskeletal system * Sufficient motivation to maintain professional participation Exclusion Criteria: * No completion of all work-specific rehabilitation modules * Acute or decompensated disease states with severe functional limitations (i.e. not able to continue with the rehabilitation programme)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

IMBA - Profile comparison

Timeframe: 3 or 4 weeks of inpatient rehabilitation

Employment history

Timeframe: 6 months after finishing rehabilitation

Trial details

NCT IDNCT07700017

SponsorPensionsversicherungsanstalt

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-07-07

View on ClinicalTrials.gov More Musculoskeletal Diseases or Conditions trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.